April 2020 Update: Stephen Sheller has been recognized by the American Association for Justice with AAJ’s 2019 Top Verdict Award. “Each year, American Association for
A recent ProPublica investigative report calls into question the Trump Administration’s commitment to ending the opioid crisis, criminally charging those responsible, and ensuring that protections
The Pennsylvania Supreme Court declined to hear Janssen Pharmacuetical’s request for an appeal of a lower courts decision to reinstate the lawsuit of a Texas man who took Risperdal as a
In a rare admission to PBS Frontline & the Finical Times, a pharmaceutical executive acknowledged that he knowingly orchestrated an illegal scheme to boost sales of
Philadelphia Court of Common Pleas Judge Kenneth Powell reduced an October 2019 $8 billion punitive damages verdict against J&J to $6.8 million. A jury had
Plaintiffs’ in the multi-district litigation, which consisting of more than 2,500 cities and counties, suing opioid manufacturers and distributors for their role in the opioid crisis
The Stephen and Sandra Sheller 11th Street Family Health Services of Drexel University is one of the many ways that the Sheller family gives back
A Pennsylvania Superior Court has rejected Johnson & Johnson’s appeal of a 2016 $70 million verdict awarded to a 20 year-old Tennessee man, Andrew Yount
In a 6 to 1 decision, the Pennsylvania Supreme Court opened the door for thousands of pending Risperdal injury cases to proceed to trial. The
Stephen A. Sheller, founder of Sheller PC, is often sought for his expertise in litigation against pharmaceutical manufacturers whose products cause harm to consumers. He recently has one
October 9, 2019: Late yesterday a Philadelphia jury rendered an $8 billion punitive damages verdict against pharmaceutical company Johnson & Johnson for illegally marketing the antipsychotic drug Risperdal, putting
Several positive developments this month for young men injured from taking the Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals.
Sheller, P.C.
1515 Market Street, Suite 1100
Philadelphia, PA 19102
Phone: 215-790-7300
info@sheller.com
